Deakin home > Deakin University Library > Deakin Research Online > Pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD)

Pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD)

McNamara, Kevin, Bunker, Stephen, Dunbar, James, Duncan, Gregory, Emery, Jon, Howarth, Helen, George, Johnson, Jackson, Shane, Janus, Eward, O'Reilly, Sharleen and Peterson, Gregory 2010, Pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD) Australian Government - Department of Health and Ageing, [Canberra, A.C.T.].

Attached Files (Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name Description MIMEType Size Downloads

Title Pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD)
Author(s) McNamara, Kevin
Bunker, Stephen
Dunbar, James
Duncan, Gregory
Emery, Jon
Howarth, Helen
George, Johnson
Jackson, Shane
Janus, Eward
O'Reilly, Sharleen
Peterson, Gregory
Publication date 2010
Total pages 85 p.
Publisher Australian Government - Department of Health and Ageing
Place of Publication [Canberra, A.C.T.]
Summary Cardiovascular disease (CVD) accounts for 18% of disease burden in Australia, and 35% of deaths. Evidence- based management of CVD risk requires systematic consideration of individual risk factors and overall CVD risk, and a balanced approach to lifestyle modification, the optimal use of medicines, and medicines adherence.

This project examines a pHot model for primary prevention of CVD in community pharmacy aimed at improving quality of care. Pharmacists from ten pharmacies received training in CVD risk factor management and facilitating patient lifestyle modification.

They recruited 70 participants aged 50-74 years, taking medicines for blood pressure (BP) or cholesterol, and without diabetes or CVD, At baseline, research assistants conducted a clinical assessment of anthropometric and biomedical risk factors, and conducted interviews to examine health behaviours, medicines use and related issues. Data was analysed by a consultant pharmacist and summary reports produced, with recommendations and targets for risk reduction. These were addressed by patients and their community pharmacists over five monthly sessions. At follow up, the relative risk reduction for CVD onset over the next five years was 24%, contributed to by reductions in mean systolic BP (-7mmHg), diastolic PP (-5 mmHg), total:HDL cholesterol ratio (—0.2), waist circumference (—2cm in males, —0.7cm in females) and other risk factors.

Several key health behaviours improved, including diet quality and physical activity levels. Prevalence of non-adherence to cardiovascular medicines dropped by 1 6% to 22%.

The potential health benefits from this intervention need to be confirmed via larger, controlled clinical trials. Overall, this appears to be a feasible and potentially effective public health measure.
Language eng
Field of Research 111717 Primary Health Care
Socio Economic Objective 920499 Public Health (excl. Specific Population Health) not elsewhere classified
HERDC Research category A5 Minor research monograph
HERDC collection year 2010
Persistent URL http://hdl.handle.net/10536/DRO/DU:30023835

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in Deakin Research Online is owned by the author, with all rights reserved.

Versions
Version Filter Type
Access Statistics: 431 Abstract Views, 4 File Downloads  -  Detailed Statistics
Created: Mon, 22 Feb 2010, 13:25:23 EST by Liz Jackway